Matthieu Boucher

In this article by McIntyre and colleagues, relapse rates and predictors of relapse were evaluated in 2 randomized, placebo-controlled trials of desvenlafaxine for major depressive disorder.

The authors of this article conducted a post hoc analysis of data from 8 short-term and 1 longer-term double-blind, placebo-controlled studies of patients with major depressive disorder treated with...